Augmedix

What Augmedix actually is

Augmedix is the original ambient clinical documentation company. Founded in 2012, it spent its first decade scaling a Google-Glass remote-scribe service — clinician wears the camera, off-shore scribes type the note in real time — and evolved through several model generations into an ambient AI documentation product line consisting of three main offerings: Augmedix Go (fully automated AI scribe), Augmedix Live (real-time scribe with a human in the loop), and Augmedix Notebuilder (asynchronous note generation reviewed by trained medical documentation specialists).

The strategic distinction from purely-AI competitors like Abridge, Nabla, and Suki is the hybrid model. Augmedix never abandoned the trained human reviewer; the AI handles the bulk, but a person validates the draft before it reaches the clinician. That introduces a higher per-clinician cost but tends to reduce hallucination and omission rates compared with a fully automated pipeline. For high-acuity inpatient settings, surgical care, and other domains where AI hallucinations are riskier, the hybrid workflow is a real differentiator — and it is the legacy product surface most likely to persist after the Commure consolidation.

As of late 2024, Augmedix is a brand and product line inside Commure Ambient. New procurement conversations are increasingly framed as "Commure Ambient (formerly Augmedix)" rather than as a standalone Augmedix purchase. Buyers researching Augmedix specifically should still read this profile, then jump to the Commure Ambient profile for current platform context.

Deployment posture

Augmedix is delivered as cloud SaaS under a BAA, with the hybrid AI-plus-human workflow making it less of a pure software contract than an outsourced documentation service. There is no customer-tenanted on-prem deployment, and the trained medical documentation specialists who validate notes are an operational dependency in addition to the underlying inference infrastructure. The historical reference customer base ranges from large U.S. health systems (Sutter Health, CommonSpirit, Dignity Health, Catholic Health Initiatives) to specialty groups and individual practices.

The evidence base

Augmedix's evidence base is dominated by operational deployment scale, public-company disclosures (2024 and earlier), and the long history of hybrid AI-plus-human workflow at health systems. It has fewer peer-reviewed publications than Nabla or Abridge but a longer operational track record than either.

• checkTwelve-plus years of clinical operation. Augmedix has the longest in-production ambient-documentation operating history in the category, predating LLM-based competitors by more than a decade.
• checkHybrid-model evidence advantage. The human-in-the-loop Notebuilder Live workflow tends to outperform fully autonomous scribes on omission and attribution accuracy. The trade-off is unit economics and scalability — exactly the trade-off that motivated the take-private acquisition.
• checkPublic-company financial disclosure (2024). $13.5M Q1 2024 revenue, 40% YoY growth, $6.5M net loss. Sutter Health, CommonSpirit, Dignity Health among the largest disclosed health-system customers prior to the Commure transaction.
• closeNo public RCT on the AI-only Go tier. Buyers comparing the Augmedix Go autonomous mode to Abridge or Nabla on apples-to-apples grounds should weight the absence of an RCT and ask Commure for the equivalent measurement framework in any pilot.

Privacy and compliance posture

Augmedix runs HIPAA-aligned cloud infrastructure with a BAA, and historically has operated additional access controls around the human reviewer layer — including controlled-access workstations and audited workflows for the medical documentation specialists who handle PHI. Post-acquisition, the compliance program is now integrated into the broader Commure trust posture; buyers should ask explicitly for the updated, Commure-branded compliance attestations rather than relying on pre-2024 Augmedix-only artifacts.

What it does not offer: a customer-tenanted on-prem deployment. The trust model is "vendor cloud plus controlled-access human reviewers, audited, contractually bound." For most U.S. health systems this is unremarkable. For Canadian hospitals constrained by Ontario PHIPA, Alberta HIA, Quebec Law 25, or BC FIPPA, the binding question is where Commure / Augmedix will hold the data and whether the contractual residency commitment matches the regulator's interpretation of cross-border PHI flow.

Strengths and limitations, plainly

Where Augmedix fits versus an on-prem alternative

The honest framing for a directory reader weighing Augmedix against a hospital-owned stack:

Augmedix is the right answer for organizations whose safety posture demands a human in the documentation loop and who are comfortable with the cost and external-dependency trade-off. It is the wrong answer when the constraint is "PHI cannot leave the building" or "no third-party humans on patient encounters."

Where this fits in the WalledCare directory

Augmedix is the legacy and hybrid-workflow entry in the AI Scribes category. The closest current peer is Heidi Health — both have long market histories outside dominant U.S. enterprise contracts, though Heidi is fully AI-native and clinician-led while Augmedix is hybrid AI+human and enterprise-led. For current procurement, buyers will be comparing the integrated platform: Commure Ambient for the post-acquisition product, Abridge for Epic-first U.S. systems, and Nabla for the peer-reviewed RCT comparator. The canonical permalink for this page is /directory/vendors/augmedix/.

If your team is at "we want a safety-conservative hybrid AI-plus-human documentation workflow," Augmedix (now under Commure) belongs on the shortlist. If your team is at "we cannot route encounter audio outside our hospital network," skip the demo and read our reference stack for hospital-owned clinical AI instead.

Quick facts

Use Augmedix when human-in-the-loop documentation is the requirement

Augmedix earns shortlist attention specifically when the organization values a trained human reviewer in the documentation workflow more than the price point or speed of a fully-AI competitor. WalledCare's pilot process scopes the comparison concretely — same workflow, same evaluation rubric, real numbers for the hybrid path and the hospital-owned alternative.

send Request a WalledCare pilot arrow_back All vendors